Faculty

Institution

Unit

Venue

Theocharis Panaretakis

The University of Texas MD Anderson Cancer Center

Affiliations

Division Of Medical Oncology

The University of Texas MD Anderson Cancer Center

NoneTheocharis Panaretakis is currently serving as a Division Of Medical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Theocharis Panaretakis

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

cell biology cell death cancer cells immunology prostate cancer pharmacology oncogenes tumor biology oncology apoptosis cancer biology cell signaling therapeutic targets tumor microenvironment cellular therapy molecular cancer molecular biology tumor targeting medicinal research extracellular microvesicles cancer treatment immune responses cancer immunotherapy molecular cell biology prostatic disease leukemia signaling pathways hematological malignancies anti-cancer agents genitourinary cancers vascular biology cancer care cell regulation autophagy pharmacotherapy cellular physiology cell autophagy cancer genomics cancer immunosurveillance reactive oxygen species immunogenic cell death enzyme inhibition applied pharmacology cellular biochemistry treatment and prevention cellular immune responses myeloid neoplasia angiogenesis calreticulin exposure rodent peroxisome proliferator perfluorooctanoic acid endothelial-to-osteoblast transition in vivo systems malignant disease clinical immunology lymphoid neoplasia biological microenvironments malignant blood disorders cell cycle castration-resistant prostate cancer lateral spread allostatic load early detection localized excited state inhibitory activity host specificity cancer cell death dendritic cells consensus guidelines pre-apoptotic calreticulin exposure molecular characteristics uvc light-induced apoptosis tumor cell-derived exosomes key-lock paradigm nuclear dna acute apoptosis

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 3123: Fracturing the Tumor-Bone Alliance in Metastatic Prostate Cancer With Ra-223. Cancer Research (2025)

Pablo SanchisAgustina SabaterJuan BizzottoGaston PascualNicolas AnselminoJiabin DongJun YangGaniraju ManyamBradley BroomZhongcheng ShiShixia HuangRocio SeniukEleonora DondossolaTeocharis PanaretakisJohn AraujoPeter ShepherdPatricia TroncosoNora NavoneChristopher J. LogothetisDaniel E. FrigoElba VazquezPaul CornGeraldine GueronEstefania Labanca

cancer researchcancer biologytumor-bone allianceprostate cancermetastatic prostate cancer

Spatial Immune Profiling of Bone-Metastatic Castration-Resistant Prostate Cancer Reveals Radium-223 Immunomodulates the Bone-Tumor Microenvironment. Prostate Cancer and Prostatic Diseases (2025)

cancer immunotherapycellular therapyradiation oncologycancer cellsimmunotherapycancer immunosurveillanceimmunologyimmunoeditingcancer discoveryprostate cancertumor targetingbone-tumor microenvironmenttumor microenvironmentradium-223 immunomodulatesspatial immune profiling

Adport-601: First-In-Human Study of Adenosine 2A (A2A) and Adenosine 2B (A2B) Receptor Antagonists in Patients With Select Advanced Solid Tumors.. Journal of Clinical Oncology (2024)

Lawrence FongMohamad Adham SalkeniAnthony B. El-KhoueiryJaspreet Singh GrewalWilliam J TesterRussell Kent PachynskiDaniel FrigoTheocharis PanaretakisDesa Rae Electa PastoreRobert A. KramerGeorge GreenJustin P. FairchildIan B. WaltersGerald Steven FalchookSumit Kumar Subudhi

receptorsanti-cancer agentsoncologyradiation oncologycancer researchreceptor antagonistscancer carefirst-in-human studypharmacologycancer treatmenttumor targetingclinical researchpharmacotherapymedicinal research

Bigh3 Mediates Apoptosis and Gap Junction Failure in Osteocytes During Renal Cell Carcinoma Bone Metastasis Progression. Cancer Letters (2024)

Tianhong PanFengshuo LiuXiaoxin HaoShubo WangMurtaza WasiJian H. SongValerae O. LewisPatrick P. LinBryan MoonJustin E. BirdTheocharis PanaretakisSue-Hwa LinDanielle WuMary C. Farach-CarsonLiyun WangNingyan ZhangZhiqiang AnXiang H.-F. ZhangRobert L. Satcher

cancer immunotherapymedicinecancer biologygap junction failuremetastasistumor biologycellular therapyapoptosiscancer researchoncologycancer carecancer treatmenttreatment and preventionbone researchcell deathsurgical oncologydermatologyhealth sciencesbone health

Body Composition as a Determinant of the Therapeutic Index With Androgen Signaling Inhibition. Prostate Cancer and Prostatic Diseases (2024)

Andrew W. HahnRebecca S. TidwellPatrick G. PilieYao YuJingjing LiuDevaki Shilpa SurasiMark TitusJianhua ZhangNeha VenkateshTheocharis PanaretakisJustin R. GreggAmado J. ZuritaBilal A. SiddiquiPaul G. CornSumit K. SubudhiPavlos MsaouelEfstratios KoutroumpakisChad D. HuffAna AparicioJennifer L. McQuadeDaniel E. FrigoChristopher J. Logothetis

urologyprostatic diseasebody compositionprostate cancertherapeutic index

Leptin Levels Are Associated With Coronary Artery Calcification in Patients With Advanced Prostate Cancer. The Oncologist (2024)

Efstratios KoutroumpakisNeha VenkateshAna AparicioJuhee SongTheocharis PanaretakisAnita DeswalChristopher J LogothetisDaniel E FrigoAndrew W Hahn

coronary artery calcificationadvanced prostate cancerprostate canceroncology

Prostate Cancer–Induced Endothelial-Cell-To-Osteoblast Transition Drives Immunosuppression in the Bone–Tumor Microenvironment Through Wnt Pathway–Induced M2 Macrophage Polarization. Proceedings of the National Academy of Sciences (2024)

bone–tumor microenvironmenturologycellular therapycancer growthcancer biologycell biologycancer cellsimmunologyprostate cancerm2 macrophage polarizationtumor microenvironmentbiological microenvironments

Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice. Cancers (2024)

orthopaedic researchtrabecular boneosteoporosisbone mineral densitybone researchbone metabolismcell biologybone fracturebone remodelingosteoblast reporter micephysiologybone diseasebone homeostasis

Additional File 2 of a Gata2-Cdc6 Axis Modulates Androgen Receptor Blockade-Induced Senescence in Prostate Cancer. Open MIND (2023)

aging cellurologyprostatic diseasecancer biologycell biologycell signalingcancer cellsoncogenesendocrine-related cancersadditional file 2therapeutic targetsprostate cancerhormonal receptorgata2-cdc6 axis modulates

A Gata2-Cdc6 Axis Modulates Androgen Receptor Blockade-Induced Senescence in Prostate Cancer. Journal of Experimental & Clinical Cancer Research (2023)

aging cellurologyprostatic diseasemolecular cancerreceptor blockade-induced senescencecancer biologycell biologycell signalingcancer cellsoncogenesendocrine-related cancershormonal receptorprostate cancersignal transductiongata2-cdc6 axis modulatescarcinogenesis

1
2
3
4
5
9
10 / page

Theocharis Panaretakis

The University of Texas MD Anderson Cancer Center

Affiliations

Division Of Medical Oncology

The University of Texas MD Anderson Cancer Center

NoneTheocharis Panaretakis is currently serving as a Division Of Medical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Theocharis Panaretakis

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 3123: Fracturing the Tumor-Bone Alliance in Metastatic Prostate Cancer With Ra-223. Cancer Research (2025)

cancer researchcancer biologytumor-bone allianceprostate cancermetastatic prostate cancer

Spatial Immune Profiling of Bone-Metastatic Castration-Resistant Prostate Cancer Reveals Radium-223 Immunomodulates the Bone-Tumor Microenvironment. Prostate Cancer and Prostatic Diseases (2025)

Adport-601: First-In-Human Study of Adenosine 2A (A2A) and Adenosine 2B (A2B) Receptor Antagonists in Patients With Select Advanced Solid Tumors.. Journal of Clinical Oncology (2024)

Bigh3 Mediates Apoptosis and Gap Junction Failure in Osteocytes During Renal Cell Carcinoma Bone Metastasis Progression. Cancer Letters (2024)

Body Composition as a Determinant of the Therapeutic Index With Androgen Signaling Inhibition. Prostate Cancer and Prostatic Diseases (2024)

urologyprostatic diseasebody compositionprostate cancertherapeutic index

Leptin Levels Are Associated With Coronary Artery Calcification in Patients With Advanced Prostate Cancer. The Oncologist (2024)

Efstratios KoutroumpakisNeha VenkateshAna AparicioJuhee SongTheocharis PanaretakisAnita DeswalChristopher J LogothetisDaniel E FrigoAndrew W Hahn

coronary artery calcificationadvanced prostate cancerprostate canceroncology

Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice. Cancers (2024)

orthopaedic researchtrabecular boneosteoporosisbone mineral densitybone researchbone metabolismcell biologybone fracturebone remodelingosteoblast reporter micephysiologybone diseasebone homeostasis

Additional File 2 of a Gata2-Cdc6 Axis Modulates Androgen Receptor Blockade-Induced Senescence in Prostate Cancer. Open MIND (2023)

A Gata2-Cdc6 Axis Modulates Androgen Receptor Blockade-Induced Senescence in Prostate Cancer. Journal of Experimental & Clinical Cancer Research (2023)

1
2
3
4
5
9
10 / page